Dexamethasone implants in retinal vein occlusion: 12-month clinical effectiveness using repeat injections as-needed

To report the 12-month outcomes of the dexamethasone intravitreal implant in retinal vein occlusion (RVO), using an as-needed repeat injection protocol.Retrospective consecutive case series of 51 eyes of 49 patients with macular oedema as a result of RVO that received an intravitreal dexamethasone implant and were followed up for at least 12 months.70% of patients responded to dexamethasone implant injection with an improvement in visual acuity...